Skip to main content
. 2022 May 23;14(10):2563. doi: 10.3390/cancers14102563
ACE Angiotensin-converting enzyme
ALDH Aldehyde dehydrogenase
ARB Angiotensin receptor-blocking drug
CA Carbonic anhydrase
COX-2 Cyclooxygenase-2
DHFR Dihydrofolate reductase
Hh Hedgehog
5-LO 5-Lipoxygenase
MTX Methotrexate
MOA Mechanism of action
MDACT Multidrug adjuvant for cancer treatment
NLR Neutrophil-to-lymphocyte ratio
VEGF Vascular endothelial growth factor